HLA-C and melanoma: In a study of melanoma, the STING signaling pathway was found to increase MHC expression, promote IFN-γ expression and infiltration of TILs, while in STING-deficient melanoma, it attenuates the recognition of TILs to tumor cells and mediates resistance to immunotherapy (17).